Comparison of Endometrial Changes among Symptomatic Tamoxifen-Treated and Nontreated Premenopausal and Postmenopausal Breast Cancer Patients

This publication has 15 references indexed in Scilit:

• Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
  JNCI Journal of the National Cancer Institute, 1994
• Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer Patients
  Gynecologic Oncology, 1994
• Risk of endometrial cancer after tamoxifen treatment of breast cancer
  The Lancet, 1994
• A current view of tamoxifen for the treatment and prevention of breast cancer
  British Journal of Pharmacology, 1993
• Endometrial morphology in asymptomatic postmenopausal women
  American Journal of Obstetrics and Gynecology, 1991
• Tamoxifen in premenopausal patients with metastatic breast cancer: a review.
  Journal of Clinical Oncology, 1991
• A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
  New England Journal of Medicine, 1989
• ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
  The Lancet, 1989
• TAMOXIFEN AS RISK FACTOR FOR CARCINOMA OF CORPUS UTERI
  The Lancet, 1988
• Binding of [3h]tamoxifen in rat uterine cytosols: A comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis
  Molecular and Cellular Endocrinology, 1977